Section Arrow
SILK.NASDAQ
- Silk Road Medical
Quotes are at least 15-min delayed:2024/05/28 20:37 EDT
Last
 21.355
-0.575 (-2.62%)
Day High 
22.3 
Prev. Close
21.93 
1-M High
22.89 
Volume 
683.27K 
Bid
20.62
Ask
21.5
Day Low
20.94 
Open
22.16 
1-M Low
16.8 
Market Cap 
865.00M 
Currency USD 
P/E -- 
%Yield
10-SMA 21.86 
20-SMA 20.92 
50-SMA 19.11 
52-W High 34.13 
52-W Low 6.08 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.37/-1.24
Enterprise Value
940.63M
Balance Sheet
Book Value Per Share
3.73
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
177.13M
Operating Revenue Per Share
4.31
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
RSLSReShape Lifesciences0.2191+0.0311+16.54%-- 
CATXPerspective Therapeutics1.56+0.06+4.00%-- 
NUWENuwellis0.2873+0.038051+15.27%-- 
MDTMedtronic plc82-0.29-0.35%26.12PE
PACBPacific Biosciences of California1.875+0.005+0.27%-- 
Quotes are at least 15-min delayed:2024/05/28 20:37 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Silk Road Medical Inc is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has a new approach for the treatment of carotid artery disease called transcarotid artery revascularization, or TCAR, which it seeks to establish as the standard of care. TCAR relies on two novel concepts - minimally-invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain - and combines novel endovascular techniques with fundamental surgical principles. TCAR using its portfolio of products has been clinically demonstrated to reduce the upfront morbidity and mortality risks commonly associated with carotid endarterectomy. The company generates all of its revenue in the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.